| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 01/15/2014 | CN102341385B Piperazine compound capable of inhibiting prostaglandin d synthase |
| 01/15/2014 | CN102060903B Ginsenoside Rh2 extractive and preparation method thereof |
| 01/15/2014 | CN101757609B Method for controlling residue of organic solvent in thymic peptide alpha1 microballoon |
| 01/14/2014 | US8629123 Use of dextran sulfate |
| 01/14/2014 | US8629117 Method for stimulating the immune system |
| 01/14/2014 | US8628784 Adjuvant systems and vaccines |
| 01/14/2014 | US8628775 Methods of reducing T cell-mediated immune responses with multimeric P-selectin and/or E-selectin compounds |
| 01/12/2014 | CA2782942A1 Method for inducing immune tolerance using polymer-modified antigenic leukocytes |
| 01/09/2014 | WO2014008503A1 Methods of using ceo2 and tio2 nanoparticles in modulation of the immune system |
| 01/09/2014 | WO2014007362A1 Method for separating cyclic macrolide compound |
| 01/09/2014 | WO2014006585A1 1-phenyl-substituted heterocyclyl derivatives and their use as prostaglandin d2 receptor modulators |
| 01/09/2014 | WO2012162254A8 Inhibitors of lrrk2 kinase activity |
| 01/09/2014 | US20140011885 Organic Compounds |
| 01/09/2014 | US20140011815 Fitness assay and associated methods |
| 01/09/2014 | US20140011215 Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using elisa assays |
| 01/09/2014 | US20140010819 Method for correcting immunopathological reactions and a medicament |
| 01/09/2014 | US20140010798 Albumin fusion proteins |
| 01/09/2014 | CA2877948A1 Paramyxovirus and methods of use |
| 01/09/2014 | CA2877441A1 Complement split product c4d for the treatment of inflammatory conditions |
| 01/09/2014 | CA2876808A1 1-phenyl-substituted heterocyclyl derivatives and their use as prostaglandin d2 receptor modulators |
| 01/08/2014 | EP2682462A1 (nucleic acid)-polysaccharide complex |
| 01/08/2014 | EP2682390A1 2-aminothiazole derivative, preparation method, and use |
| 01/08/2014 | EP2682386A1 Novel vitamin d receptor modulator with partial agonist activity |
| 01/08/2014 | EP2682121A1 Pharmaceutical use of aminothiazole myd88 specificity inhibitor |
| 01/08/2014 | EP2681237A1 Antagonistic dr3 ligands |
| 01/08/2014 | EP2681195A1 Novel kinase inhibitors |
| 01/08/2014 | EP2681190A1 Pyrrolidine derivatives as selective glycosidase inhibitors and uses thereof |
| 01/08/2014 | EP2680919A2 Immunologically modified carbon nanotubes for cancer treatment |
| 01/08/2014 | EP2680878A1 Treatment for ige-mediated disease |
| 01/08/2014 | EP2680858A1 Proteasome inhibitor delanzomib for use in the treatment of lupus |
| 01/08/2014 | EP2680847A1 Pyrimidine compounds inhibiting the formation of nitric oxide and prostaglandin e2, method of production thereof and use thereof |
| 01/08/2014 | EP2680846A1 Use of n-(4-methoxyphenyl)-1-phenyl-1h-pyrazol-3-amine and related compounds |
| 01/08/2014 | CN103502239A Pyridinyl- and pyrazinyl-methyloxy-aryl derivatives useful as inhibitors of spleen tyrosine kinase (SKY) |
| 01/08/2014 | CN103501813A Tolerogenic synthetic nanocarriers to reduce antibody responses |
| 01/08/2014 | CN103501812A Tolerogenic synthetic nanocarriers for allergy therapy |
| 01/08/2014 | CN103501770A Method for producing patch, and patch |
| 01/08/2014 | CN103497258A Method for extracting and purifying active polysaccharides of wheat bran |
| 01/08/2014 | CN103497192A Modulators of TOLL-like receptors |
| 01/08/2014 | CN103497188A Compounds modulating c-fms and/or c-kit activity and uses therefor |
| 01/08/2014 | CN103497185A Pyrazolo(3, 4-B)pyridine derivatives as phosphodiesterase inhibitors |
| 01/08/2014 | CN103495180A Freezing and drying protecting agentCryoprotectant for porcine reproductive and respiratory syndrome compound inactivated vaccine |
| 01/08/2014 | CN103495169A Methods and compositions for treatment and control of multiple myeloma |
| 01/08/2014 | CN103495166A Preparation method of complex live vaccine for porcine reproductive and respiratory syndrome |
| 01/08/2014 | CN103495165A Method of administering anti-TNFalpha antibodies |
| 01/08/2014 | CN103495152A Thymopentin-containing medicine composition, as well as preparation and preparation method thereof |
| 01/08/2014 | CN103495144A Medicament for treating allergic rhinitis |
| 01/08/2014 | CN103495113A Traditional Chinese medicine composition for treating henoch-schonleinpurpura |
| 01/08/2014 | CN103495105A Chinese medicine composition containing hematogenesis pills and application of Chinese medicine composition |
| 01/08/2014 | CN103495018A Method for preparing refreshing Shengmai oral liquid |
| 01/08/2014 | CN103494996A Pharmaceutical composition for improving immunity of livestock and poultry and preparation method of pharmaceutical composition |
| 01/08/2014 | CN103494987A Proved recipe for treating influenza |
| 01/08/2014 | CN103494956A Prescription for preventing and treating influenza and preparation method thereof |
| 01/08/2014 | CN103494929A Houttuynia cordata injectable in situ gel as well as preparation method thereof |
| 01/08/2014 | CN103494928A Preparation method for compound houttuynia cordata preparation |
| 01/08/2014 | CN103494921A Traditional Chinese medicinal paper and manufacturing method thereof |
| 01/08/2014 | CN103494914A 复方黄芪免疫激活注射液 Compound Astragalus injection of immune activation |
| 01/08/2014 | CN103494913A Preparation method of compound radix astragali immune activation injection |
| 01/08/2014 | CN103494880A Mouth-opening medicine for chickens and preparation method of medicine |
| 01/08/2014 | CN103494865A Composition of human stem cell and gynostemma pentaphyllum bioactive substances and preparation method thereof |
| 01/08/2014 | CN103494862A Method for extracting olive polyphenol from olive processing waste liquor |
| 01/08/2014 | CN103494858A Method for enriching total flavonoids in taraxacum mongolicum with macroporous resins |
| 01/08/2014 | CN103494852A Method for enriching total flavonoids in herba artemisiae scopariae with macroporous resins |
| 01/08/2014 | CN103494817A Methods and compoistions used for treatment and control of multiple myeloma |
| 01/08/2014 | CN103494789A Preparation method of sea-buckthorn polysaccharide soft capsule |
| 01/08/2014 | CN103494785A Montelukast sodium chewable tablet and preparation method thereof |
| 01/08/2014 | CN103494781A Montelukast sodium chewing tablet prescription and preparation process thereof |
| 01/08/2014 | CN103494209A Maca composite health care medicine |
| 01/08/2014 | CN103494197A Health-care food with functions of enhancing immunity and assisting to reduce blood sugar and preparation method of food |
| 01/08/2014 | CN103494194A Novel formula and production technology of drone, ginseng and pseudo-ginseng capsule product |
| 01/08/2014 | CN103493969A Method for producing giant salamander polypeptide powder |
| 01/08/2014 | CN103142544B Ubenimex capsule composition and preparation method thereof |
| 01/08/2014 | CN102824529B Traditional Chinese medicine for nourishing yin and yang, tonifying qi and producing blood, and prolonging life |
| 01/08/2014 | CN102764437B Methoxsalen injection and preparation method thereof |
| 01/08/2014 | CN102671069B Medicinal composition for treating allergic rhinitis |
| 01/08/2014 | CN102631394B Traditional Chinese medicine composition capable of improving immunity and resisting fatigue |
| 01/08/2014 | CN102477081B Application of novel polypeptide in diagnosis of sjogren's syndrome |
| 01/08/2014 | CN102399289B Human IgE (immunoglobulin E) Fab (fragment ab) against human and coding gene and application thereof |
| 01/08/2014 | CN102382102B Amide compound |
| 01/08/2014 | CN101426772B Benzotriazine inhibitors of kinases |
| 01/07/2014 | US8623881 Inhibitors of human phosphatidylinositol 3-kinase delta |
| 01/07/2014 | US8623833 Compositions and methods for enhancing drug delivery across and into epithelial tissues |
| 01/07/2014 | US8623643 Antisense oligonucleotide modulation of STAT3 expression |
| 01/07/2014 | US8623411 Modified release compositions comprising tacrolimus |
| 01/07/2014 | US8623410 Modified release compositions comprising tacrolimus |
| 01/07/2014 | US8623374 Method for enhancing immune response with peptide |
| 01/07/2014 | US8623355 Methods for suppressing acute rejection of a heart transplant |
| 01/07/2014 | CA2560922C Improvements in or relating to compounds for use in the treatment of aids and other viral diseases and hiv-related infections and compositions containing such compounds, methods of treating such diseases and infections and methods of making such compounds and compositions |
| 01/07/2014 | CA2542504C Lipids containing omega-3 and omega-6 fatty acids |
| 01/07/2014 | CA2453967C Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 01/07/2014 | CA2441213C Cd4+cd25+ regulatory t cells from human blood |
| 01/03/2014 | WO2014004470A1 Treatment of lupus, fibrotic conditions, and inflammatory myopathies and other disorders using pi3 kinase inhibitors |
| 01/03/2014 | WO2014003483A1 Fused pyrimidine derivatives having inhibitory activity on fms kinases |
| 01/03/2014 | WO2014003008A1 Novel histamine liberator contained in human sweat |
| 01/03/2014 | WO2014002232A1 Hyaluronic acid decomposition inhibitor comprising rosemary extract and retinol acetate |
| 01/03/2014 | WO2014002057A1 Pyrrolidine derivatives and their use as complement pathway modulators |
| 01/03/2014 | WO2014002054A1 Pyrrolidine derivatives and their use as complement pathway modulators |
| 01/03/2014 | WO2014002053A1 Pyrrolidine derivatives and their use as complement pathway modulators |
| 01/03/2014 | WO2014002052A1 Pyrrolidine derivatives and their use as complement pathway modulators |
| 01/03/2014 | WO2014000032A1 Phenyl amino pyrimidine bicyclic compounds and uses thereof |
| 01/03/2014 | WO2009158026A9 Hydrazonamide compounds that modulate hsp90 activity |